AAAAAA

   
Results: 1-10 |
Results: 10
PREDOMINANT EXPRESSION OF 5-ALPHA-REDUCTASE TYPE-1 IN PUBIC SKIN FROMNORMAL SUBJECTS AND HIRSUTE PATIENTS
Authors: MESTAYER C BERTHAUT I PORTOIS MC WRIGHT F KUTTENN F MOWSZOWICZ I MAUVAISJARVIS P
Citation: C. Mestayer et al., PREDOMINANT EXPRESSION OF 5-ALPHA-REDUCTASE TYPE-1 IN PUBIC SKIN FROMNORMAL SUBJECTS AND HIRSUTE PATIENTS, The Journal of clinical endocrinology and metabolism, 81(5), 1996, pp. 1989-1993
ESTRADIOL STIMULATES C-MYC PROTOONCOGENE EXPRESSION IN NORMAL HUMAN BREAST EPITHELIAL-CELLS IN CULTURE
Authors: LEYGUE E GOLWINKLER R GOMPEL A LOUISSYLVESTRE C SOQUET L STAUB S KUTTENN F MAUVAISJARVIS P
Citation: E. Leygue et al., ESTRADIOL STIMULATES C-MYC PROTOONCOGENE EXPRESSION IN NORMAL HUMAN BREAST EPITHELIAL-CELLS IN CULTURE, Journal of steroid biochemistry and molecular biology, 52(4), 1995, pp. 299-305
LACK OF INDUCTION OF ENDOMETRIAL HYPERPLASIA WITH TAMOXIFEN
Authors: TOURAINE P DRIGUEZ P CARTIER I YANEVA H KUTTENN F MAUVAISJARVIS P
Citation: P. Touraine et al., LACK OF INDUCTION OF ENDOMETRIAL HYPERPLASIA WITH TAMOXIFEN, Lancet, 345(8944), 1995, pp. 254-255
RECOMMENDATIONS OF THE FEDERATION OF FREN CH CANCER CENTERS ABOUT ESSAYS WITH TAMOXIFEN IN BREAST-CANCER FNCLCC
Authors: EISINGER F LAFFARGUE F MARANINCHI D MAUVAISJARVIS P MOATTI JP NAMER M PUJOL H PHILIP T SANCHOGARNIER H
Citation: F. Eisinger et al., RECOMMENDATIONS OF THE FEDERATION OF FREN CH CANCER CENTERS ABOUT ESSAYS WITH TAMOXIFEN IN BREAST-CANCER FNCLCC, Bulletin du cancer, 82, 1995, pp. 237-238
5-ALPHA-REDUCTASES - PHYSIOLOGY AND PATHO LOGY
Authors: MOWSZOWICZ I BERTHAUIT I MESTAYER C WRIGHT F KUTTENN F MAUVAISJARVIS P
Citation: I. Mowszowicz et al., 5-ALPHA-REDUCTASES - PHYSIOLOGY AND PATHO LOGY, Annales d'Endocrinologie, 56(6), 1995, pp. 555-559
HORMONAL PREVENTION OF BREAST-CANCER - TI ME FOR HYPOTHESIS
Authors: MAUVAISJARVIS P TOURAINE P
Citation: P. Mauvaisjarvis et P. Touraine, HORMONAL PREVENTION OF BREAST-CANCER - TI ME FOR HYPOTHESIS, Bulletin du cancer, 81(8), 1994, pp. 715-719
PROGESTOGEN USE AND DECREASED RISK OF BREAST-CANCER IN A COHORT STUDYOF PREMENOPAUSAL WOMEN WITH BENIGN BREAST DISEASE
Authors: PLUBUREAU G LE MG SITRUKWARE R THALABARD JC MAUVAISJARVIS P
Citation: G. Plubureau et al., PROGESTOGEN USE AND DECREASED RISK OF BREAST-CANCER IN A COHORT STUDYOF PREMENOPAUSAL WOMEN WITH BENIGN BREAST DISEASE, British Journal of Cancer, 70(2), 1994, pp. 270-277
A POINT MUTATION IN THE 2ND ZINC-FINGER OF THE DNA-BINDING DOMAIN OF THE ANDROGEN RECEPTOR GENE CAUSES COMPLETE ANDROGEN INSENSITIVITY IN 2SIBLINGS WITH RECEPTOR-POSITIVE ANDROGEN RESISTANCE
Authors: MOWSZOWICZ I LEE HJ CHEN HT MESTAYER C PORTOIS MC CABROL S MAUVAISJARVIS P CHANG CS
Citation: I. Mowszowicz et al., A POINT MUTATION IN THE 2ND ZINC-FINGER OF THE DNA-BINDING DOMAIN OF THE ANDROGEN RECEPTOR GENE CAUSES COMPLETE ANDROGEN INSENSITIVITY IN 2SIBLINGS WITH RECEPTOR-POSITIVE ANDROGEN RESISTANCE, Molecular endocrinology, 7(7), 1993, pp. 861-869
HORMONAL PREVENTION OF THE BREAST-CANCER - ARE WE HEADING IN THE RIGHT DIRECTION
Authors: TOURAINE P KUTTENN F MAUVAISJARVIS P
Citation: P. Touraine et al., HORMONAL PREVENTION OF THE BREAST-CANCER - ARE WE HEADING IN THE RIGHT DIRECTION, MS. Medecine sciences, 9(12), 1993, pp. 1386-1391
THYROID-HORMONE RESISTANCE SYNDROME
Authors: MECHAIN C LEGER A FELDMAN S KUTTENN F MAUVAISJARVIS P
Citation: C. Mechain et al., THYROID-HORMONE RESISTANCE SYNDROME, La Presse medicale, 22(37), 1993, pp. 1870-1875
Risultati: 1-10 |